Michael Mulqueen

Michael Mulqueen

Michael Mulqueen

VP of Business Development - eTheRNA immunotherapies

Michael Mulqueen started his career with Roche as part of the business development department with a strong focus on in-licensing and alliance management. He left Roche to set up Synosia Therapeutics AG. From this point on, he worked with a number of European biotech companies with a focus on out-licensing and partnering. Latterly, he was VP for BD and Licensing with Silence Therapeutics in the RNAi field.

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners